click below
click below
Normal Size Small Size show me how
CNS2-3
| Brand | Generic | Category | Indications | Essential Knowledge |
|---|---|---|---|---|
| Focalin, Focalin XR | dexmethylphenidate (PO) | CNS stimulant | ADHD | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse Other Notes: CI within 14 days of MAOI |
| Adderall, Adderall XR | dextroamphetamine and amphetamine (PO) | CNS stimulant | ADHD, narcolepsy | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse Other Notes: CI within 14 days of MAOI |
| Vyvanse | lisdexamfetamine (PO) | CNS stimulant | ADHD | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse Other Notes: CI within 14 days of MAOI |
| PO: Concerta, Ritalin Patch: Daytrana | methylphenidate (PO, transdermal) | CNS stimulant | ADHD, narcolepsy | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse Other Notes: CI within 14 days of MAOI |
| Intuniv | guanfacine (PO) | Selective alpha2a agonist | ADHD, HTN | Key Side Effects: bradycardia, hypotension, sedation, skin rash, xerostomia, constipation Other Notes: do not abruptly discontinue |
| Mirapex | pramipexole (PO) | Dopamine agonist | Parkinson's disease, RLS | Key Side Effects: nausea, hallucination, dizziness, drowsiness, compulsive behaviors, orthostasis |
| Requip | ropinirole (PO) | Dopamine agonist | Parkinson's disease, RLS | Key Side Effects: nausea, hallucination, dizziness, drowsiness, compulsive behaviors, orthostasis |
| Sinemet, Sinemet CR | carbidopa and levodopa (PO) | Decarboxylase inhibitor (carbidopa), dopamine precursor (levodopa) | Parkinson's disease | Key Side Effects: nausea, orthostatic hypotension, dyskinesis, Other Notes: CI within 14 days of MAOI, CI in narrow-angle glaucoma; do not abruptly discontinue |
| Nameda | memantine (PO) | N-methyl D-aspartate (NMDA) antagonist | Dementia | Key Side Effects: constipation, confusion, dizziness, headache |
| PO: Aricept Transdermal: Adlarity | donepezil (PO, transdermal) | Cholinesterase inhibitor | Dementia | Key Side Effects: nausea, vomiting, diarrhea |
| Lithobid | lithium (PO) | Antimanic agent | Bipolar disorder | |
| Imitrex | sumatriptan (PO, intranasal, SQ) | Antimigraine | Migraine | |
| Maxalt | rizatriptan (PO) | Antimigraine | Migraine | |
| Haldol | haloperidol (PO, IV, IM) | First-generation antipsychotic | Schizophrenia | |
| Clozaril | clozapine (PO) | Second-generation antipsychotic | Treatment-resistant schizophrenia | |
| PO/IM: Abilify IM: Aristada | aripiprazole (PO, IM) | Second-generation antipsychotic | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | |
| Seroquel, Seroquel XR | quetiapine (PO) | Second-generation antipsychotic | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | |
| Latuda | lurasidone (PO) | Second-generation antipsychotic | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | |
| Zyprexa | olanzapine (PO, IM) | Second-generation antipsychotic | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | |
| PO: Risperdal IM: Risperdal Consta | risperidone (PO, IM) | Second-generation antipsychotic | Schizophrenia |